Perrigo company

Major-Pharmaceuticals

PRGO


The Sharp Building
Dublin , 2

Executive/
Director

Price

  • Last Close
  • $ 25.94
    $ -0.04 -0.15 %
    Jan 3, 2025
  • 52-Week High/Low
  • $36.15 - $25.42
  • YTD
  • 0.9%

  • Trading Volume
  • 38,765
  • Market Cap Full
  • $ 3.5B
  • Shares Outstanding
  • 135.5M
    Nov 3, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -11.5% -20.1% -4.2% 24.3% -5% -9.8% -0.4% 5.2% - 0.9%
Q2 -29% 14% -9.8% -4.2% 4% 13.3% 4.7% -5.3% -20.8% -
Q3 2% 12.3% -3.7% 14.2% 8% 3.2% -12.1% -5.9% 2.1% -
Q4 -9.7% 1.3% -45.3% -6.8% -2.3% -17.8% -4.4% 2.7% -8% -
J F M A M J J A S O N D
2025 0.9% - - - - - - - - - - -
2024 -0.4% -18.2% 22.6% -6.6% -8.5% -7.6% 11.7% 2.1% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    -13%-42%6%-55%34%-13%-13%-12%-6%-20%1%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 1.75 1.05 0.57 0.47 0.77 0.28 -0.02 -0.02
Q2 1.93 1.22 0.26 0.07 0.44 -0.43 -0.48 0.06
Q3 1.65 1.39 -0.49 0.67 -1.13 -0.44 -0.37 0.10
Q4 1.24 1.28 0.61 -0.14 -1.27 0.07 -0.17 -
A 6.6 4.9 1 1.1 -1.2 -0.5 -1 0.14

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Dividend +

Dividend +

2020 2021 2022 2023 2024
Q1 0.23 0.24 0.26 0.27 0.28
Q2 0.23 0.24 0.26 0.27 0.28
Q3 0.23 0.24 0.26 0.27 0.28
Q4 0.23 0.24 0.26 0.27 0.28
A 0.92 0.96 1.04 1.08 1.12
2018 2019 2020 2021 2022 2023
Mar - 135.9 136.1 133.1 133.8 134.6
Jun 138.5 136 136.3 133.5 134.6 135.3
Sep 136.8 136.1 136.5 133.7 134.6 135.4
Dec 135.9 136.1 136.5 133.8 134.6 135.5

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 2.6 2.7 2.7 3.2 3.3
Fixed Asset Turnover 3.4 3.3 3.7 3.7 4
Total Asset Turnover 0.4 0.4 0.4 0.4 0.4
Leverage
Debt Ratio 1.5 0.8 1.1 1.2 1.1
Debt – Equity Ratio 0.8 0.6 0.6 0.6 0.5
Interest Coverage 0.4 0.9 0.4 3.5 2.2
Equity multiplier 0.3 0.2 0.2 0.2 0.2